Effects of low doses of Li carbonate injected into mice. Functional changes in kidney seem to be related to the oxidative status;Effets chroniques de faibles doses de carbonate de lithium chez la souris. Relations entre statut oxydant et modifications fonctionnelles et structurales des reins et du cerveau

Comptes Rendus - Biologies

Volumn 331, Issue 1, 2008, Pages 23-31

  Nciri, Riadh ^a,b   Salah Allagui, Mohamed ^a,b   Croute, Françoise ^b   Vincent, Christian ^b   Elfeki, Abdelfattah ^a  

^a University of Sfax   (Tunisia)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Antioxidant activities; Brain; Kidney; Lithium; TBARS

Indexed keywords

CATALASE; CREATININE; GLUTATHIONE PEROXIDASE; LITHIUM CARBONATE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UREA;

ANTIOXIDANT; BRAIN; CARBONATE; LITHIUM; RODENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DENDRITE; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; DRUG MEGADOSE; ENZYME ACTIVITY; HISTOPATHOLOGY; LIPID PEROXIDATION; LITHIUM BLOOD LEVEL; LIVER FUNCTION; LOW DRUG DOSE; MOUSE; NEPHROTOXICITY; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; UREA BLOOD LEVEL;

ANIMALS; BRAIN; BRAIN DISEASES; CATALASE; GLUTATHIONE PEROXIDASE; INJECTIONS, INTRAPERITONEAL; KIDNEY; KIDNEY DISEASES; LIPID PEROXIDATION; LITHIUM; LITHIUM CARBONATE; MALE; MICE; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

MUS;

EID: 37549062260     PISSN: 16310691     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crvi.2007.11.004     Document Type: Article

References (35)

1. Manji H.K., Moore G.J., and Chen G. Lithium at 50: Have the neuroprotective effect of this unique cation overlooked?. Biol. Psychiatry 46 (1999) 929-940
2. Schou M. Lithium treatment at 52. J. Affect. Disord. 67 (2001) 21-32
3. Joffe R.T. Does lithium save lives. J. Psychiatry Neurosci. 29 (2004) 9-10
4. Phiel C.J., Wilson C.A., Lee V.M., and Klein P.S. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 423 (2003) 435-439
5. Engel T., Goñi-Oliver P., Lucas J.-J., Avila J., and Hernández F. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert. J. Neurochem. 99 (2006) 1445-1455
6. Lazarus J.H. The effects of lithium therapy on thyroid and thyrotropin-releasing hormone. Thyroid 8 (1998) 909-913
7. Bowden C.L. Key treatment studies of lithium in manic-depressive illness: Efficacy and side effects. J. Clin. Psychiatry 59 (1998) 13-19
8. Turan T., Esel E., Tokgoz B., Aslan S., Sofuoglu S., Utas C., and Kelestimur F. Effects of short- and long-term lithium treatment on kidney functioning in patients with bipolar mood disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 26 (2002) 561-565
9. Birch N.J., Grof P., Hullin R.P., Kehoe R.F., Schou M., and Srinivasan D.P. Lithium prophylaxis: proposed guide-lines for good clinical practice. Lithium 4 (1993) 225-230
10. Dysseleer A., Buysschaert M., and Thissen J.P. Fonction rénale et lithium : À propos d'un cas. Louvain Med. 119 (2000) 241-246
11. Farres M.-T., Ronco P., Saadoun D., Remy P., Vincent F., Khalil A., and Le Blanche A.-F. Chronic lithium nephropathy: MR imaging for diagnosis. Radiology 229 (2003) 570-574
12. Allagui M.S., Hfaiedh N., Croute F., Guermazi F., Vincent C., Soleilhavoup J.-P., and Elfeki A. Side effects of low serum lithium concentrations on renal, thyroid, and sexual functions in male and female rats. C. R. Biologies 28 (2005) 900-911
13. Kielczykowska M., Pastermak K., Musik I., and Wroniska J. The effect of lithium administration in a diet on the chosen parameters of the antioxidant barrier in rats. Ann. Univ. Mariae Curie Sklodowska 59 (2004) 140-145
14. Oktem F., Ozguner F., Sulak O., Olgar S., Akturk O., Yilmaz H.R., and Altuntas I. Lithium-induced renal toxicity in rats: protection by a novel antioxidant caffeic acid phenethyl ester. Mol. Cell. Biochem. 277 (2005) 109-115
15. Efrati S., Averbukh M., Berman S., Feldman L., Dishy V., Kachko L., Weissgarten J., Golik A., and Averbukh Z. N-Acetylcysteine ameliorates lithium-induced renal failure in rats. Nephrol. Dial. Transplant. 20 (2005) 65-70
16. Engin A., Altan N., and Isik E. Erythrocyte glutathione levels in lithium-induced hypothyroidism. Drugs R. D. 6 (2005) 35-40
17. Cui J., Shao L., Young L.T., and Wang J.F. Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate. Neuroscience 23 (2007) 1447-1453
18. Shao L., Young L.T., and Wang J.F. Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biol. Psychiatry 58 (2005) 879-884
19. Frey B.N., Valvassori S.S., Reus G.Z., Martins M.R., Petronilho F.C., Bardini K., Dal-Pizzol F., Kapczinski F., and Quevedo J. Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J. Psychiatry Neurosci. 31 (2006) 326-332
20. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J. Neurochem. 97 (2006) 1634-1658
21. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 1265-1275
22. Esterbauer H. Cytotoxicity and genotoxicity of lipid-oxidation products. Am. J. Clin. Nutr. 57 (1993) 779-785
23. Aebi H. Catalase in vitro. Methods Enzymol. 105 (1984) 121-126
24. Flohe L., and Gunzler W.A. Assays of glutathione peroxidase. Methods Enzymol. 105 (1984) 114-121
25. Beauchamp C., and Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal. Biochem. 44 (1971) 276-287
26. M.S. Allagui, C. Vincent, K. Jammoussi, F. Ayedi, F. Croute, A. El Feki, Lipid peroxidation, antioxidative activities and stress protein expression (HSP72/73, GRP94) in kidney and liver of rats under carbonate lithium treatment (submitted)
27. Faruk O., Fehmi O., Osman S., Seref O., Onur A., Ramazan Y.H., and Irfan A. Lithium induced renal toxicity in rats: protection by a novel antioxidant caffeic acid phenethyl ester. Mol. Cell. Biochem. 277 (2005) 109-115
28. Shukla G.S. Mechanism of lithium action: in vivo and in vitro effects of alkali metals on brain superoxide dismutase. Pharmacol. Biochem. Behav. 26 (1987) 235-240
29. Vamecq J., Vallée L., Storme L., Gelé P., and Bordet R. Les acteurs immédiats du stress oxydant. La lettre du pharmacologue 18 (2004) 16-22
30. Chen G., Rajkowska G., Du F., Seraji-Bozorgzad N., and Manji H.K. Enhancement of hippocampal neurogenesis by lithium. J. Neurochem. 75 (2000) 1729-1734
31. Kim J.S., Chang M.Y., Yu I.T., Kim J.H., Lee S.H., Lee Y.S., and Son H. Lithium selectively increases neuronal differentiation of hippocampal neural progenitor cells both in vitro and in vivo. J. Neurochem. 89 (2004) 324-336
32. Yan X.B., Hou H.L., Wu L.M., Liu J., and Zhou J.N. Lithium regulates hippocampal neurogenesis by ERK pathway and facilitates recovery of spatial learning and memory in rats after transient global cerebral ischemia. Neuropharmacology 53 (2007) 487-495
33. Garcia-Pérez J., Avila J., and Diaz-Nido J. Lithium induces morphological differentiation of mouse neuroblastoma cells. J. Neurosci. Res. 57 (1999) 261-270
34. Orme M.H., Giannini A.L., Vivanco M.D., and Kypta R.M. Glycogen synthase kinase-3 and Axin function in a beta-catenin-independent pathway that regulates neurite outgrowth in neuroblastoma cells. Mol. Cell. Neurosci. 24 (2003) 673-686
35. Di D.E., Mudge A.W., and Maycox P.R. Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons. Bipolar Disord. 7 (2005) 33-41